Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study

• 主要な著者: Bong-Joon Kim (著者), Kyoung-Im Cho (著者), Hyuck Moon Kwon (著者), Seung-Min Choi (著者), Chang-Hwan Yoon (著者), Sang Wook Lim (著者), Seung-Jae Joo (著者), Nam Ho Lee (著者), Sang-Yup Lim (著者), Seong-Hoon Lim (著者), Hyo-Soo Kim (著者)
• フォーマット: 図書
• 出版事項: BMC, 2022-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background This study evaluated the circadian efficacy of a telmisartan 40 mg/S-amlodipine 2.5 mg fixed-dose combination (Telmisartan40/S-Amlodipine2.5) compared to telmisartan 80 mg (Telmisartan80) in patients with essential hypertension who did not respond to 2-4 weeks' treatment wit...